Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$28.08 -1.02 (-3.51%)
At close: Oct 1, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Depreciation & Amortization (CF) (2021 - 2026)

Updated

Amylyx Pharmaceuticals (AMLX) recorded Depreciation & Amortization (CF) of $100,000 in Q2 2026, down 66.7% from $300,000 a year earlier and unchanged from the prior quarter.

Analysis

Amylyx Pharmaceuticals (AMLX) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

On a TTM basis, Amylyx Pharmaceuticals' Depreciation & Amortization (CF) came in at $400,000 as of Jun 30, 2026, down 55.6% year-over-year; for FY2025, it was $500,000, down 44.4% from FY2024.

  • Annual Depreciation & Amortization (CF) has a four-year compound annual growth rate of 76.1% (FY2021 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $900,000 in FY2024 (-18.2%), $1.1 million in FY2023 (+125.9%), $487,000 in FY2022 (+836.5%) and $52,000 in FY2021.
  • Quarterly Depreciation & Amortization (CF) has ranged from $10,000 in Q3 2021 to $302,000 in Q3 2023 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined for four consecutive quarters, with an average decline of 33.4% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 950.0% in Q2 2022, against a decline of 66.7% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $100,000 (Q1 2026), $100,000 (Q4 2025) and $100,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Amylyx Pharmaceuticals 3.24 Bn 3.24 Bn - 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 200,000.00
Sep 30, 2024 200,000.00
Jun 30, 2024 200,000.00
Mar 31, 2024 300,000.00
Dec 31, 2023 301,000.00
Sep 30, 2023 302,000.00
Jun 30, 2023 281,000.00
Mar 31, 2023 204,000.00
Dec 31, 2022 182,000.00
Sep 30, 2022 165,000.00
Jun 30, 2022 105,000.00
Mar 31, 2022 35,000.00
Dec 31, 2021 22,000.00
Sep 30, 2021 10,000.00
API Access

Amylyx Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AMLX&period=max&api_key=YOUR_API_KEY